VLDLR and atherosclerosis: Zhao et al reported that in vivo AAV-mediated low-density lipoprotein receptor (Ldlr) gene correction, which can partially rescue Ldlr expression, effectively ameliorates atherosclerosis phenotypes in a Ldlr mutant mouse model 48.